Delivery Order SPE2DR25D1109-SPE2DR26FFH6V
- Not listed
- The Defense Logistics Agency (DLA) awarded a $54,119.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award was issued on December 4, 2025, with an ultimate completion date of December 5, 2025, and was competitively awarded with no set-aside designation. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a $25,878.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a non-competitive delivery order issued under an existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp was awarded a $8,445.10 delivery order by the Defense Logistics Agency (DLA) on December 1, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product for rheumatoid arthritis treatment. This is a firm fixed-price, non-set-aside contract with performance taking place at the contractor's facility in Conshohocken, Pennsylvania, and an ultimate completion date of December 2, 2025. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $70,407.28 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This competitively awarded, non-set-aside contract was executed on December 8, 2025, with a completion date of December 9, 2025, and reflects a firm fixed price arrangement. The place of performance is AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,356.21 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-competitive, firm fixed-price delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a $17,050.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract was competitively awarded with no set-aside designation and has an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $8,815.75 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order, issued on August 12, 2025, with ultimate completion by August 13, 2025, represents a single procurement under the company's larger indefinite delivery contract with DLA. The award was made on a competitive, non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,787.56 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed price delivery order was issued on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency awarded a delivery order valued at $26,393.22 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions. This competitively awarded, firm fixed-price contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025, and represents a child order under a larger contract vehicle. The delivery is to be performed...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH6VDelivery Order
The Defense Logistics Agency (DLA) awarded a $8,827.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This delivery order, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery contract vehicle, this award leverages AmerisourceBergen's extensive pharmaceutical supply capabilities within the DLA's medical supply chain. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical through December 2026 that enables the delivery of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's demonstrated ability to compete successfully for federal medical procurement contracts, combined with its comprehensive portfolio of brand-name and generic medications, positions it as a critical vendor for federal military and veteran healthcare systems. This delivery order exemplifies the routine fulfillment of specialized pharmaceutical needs through AmerisourceBergen's established prime vendor relationship with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 12/8/25 |